Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Temovate (clobetasol propionate) Ointment, 0.05%
Company:  Glaxo Wellcome Inc.
Application No.:19323 - S16
Approval Date: 11/15/96


Date created: August 1, 2003

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.